Search Results - "Ngo‐Giang‐Huong, N"

Refine Results
  1. 1

    High prevalence of CXCR4‐using viruses in vertically HIV‐1‐infected infants in Thailand by Samleerat, T, Phiayura, P, Hongjaisee, S, Sirirungsi, W, NgoGiangHuong, N, Barin, F

    Published in Journal of the International AIDS Society (01-11-2012)
    “…Purpose of the study Previous studies evaluating the frequency of CXCR4‐using strains in HIV‐1 vertically infected children restricted mainly to patients…”
    Get full text
    Journal Article
  2. 2

    Impact of highly active antiretroviral therapy on the maturation of anti‐HIV‐1 antibodies during primary HIV‐1 infection by Adalid‐Peralta, L, Grangeot‐Keros, L, Rudent, A, NgoGiangHuong, N, Krzysiek, R, Goujard, C, Deveau, C, Le Gall, M, Meyer, L, Emilie, D, Rouzioux, C

    Published in HIV medicine (01-11-2006)
    “…Objectives To study the impact of highly active antiretroviral therapy (HAART) on isotype switching and avidity maturation of HIV‐1‐specific immunoglobulin G…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Single-Dose Perinatal Nevirapine plus Standard Zidovudine to Prevent Mother-to-Child Transmission of HIV-1 in Thailand by Lallemant, Marc, Jourdain, Gonzague, Le Coeur, Sophie, Mary, Jean Yves, Ngo-Giang-Huong, Nicole, Koetsawang, Suporn, Kanshana, Siripon, McIntosh, Kenneth, Thaineua, Vallop

    Published in The New England journal of medicine (15-07-2004)
    “…In a randomized, controlled trial in Thailand, pregnant women infected with the human immunodeficiency virus (HIV) type 1 received zidovudine treatment plus a…”
    Get full text
    Journal Article
  8. 8

    Current progress in the prevention of mother-to-child transmission of hepatitis B and resulting clinical and programmatic implications by Jourdain, Gonzague, Ngo-Giang-Huong, Nicole, Khamduang, Woottichai

    Published in Infection and drug resistance (01-01-2019)
    “…There is currently no cure for hepatitis B chronic infections. Because new hepatitis B infections result mainly from perinatal transmission, preventing…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial by Bamford, Alasdair, Riault, Yoann, Nolan, Aoife, Morkunaite, Gabija, Kanjanavanit, Suparat, Pavia Ruz, Noris, Niehues, Tim, Ford, Deborah, Gibb, Diana M., Meyer, L., Cagnot, C., Hudson, F., Gao, L., Blackstone, J., Inshaw, J., Nardone, A., Bilardi, D., Chalermpantmetagul, S., Kaewbundit, A., Sripaoraya, W., Kruenual, N., Khamjakkaew, W., Hirt, D., Plonné, D., Noguera, T., Muñoz Fernández, M.A., Mangano, A., Gatto, M., Soria, A., Paredes, E., Rodallec, A., Blaise, N., Neri-Macias, A., Teixeira, C., Fernandes, A., Padrao, A., Correira, C., Tavares, M., Monteiro, F., Silva Milhiero, T., Gomes Neves, E., Corte-Real, R., Violari, A., Ramsagar, N., Liberty, A., Essack, Z., Akoojee, N., Fourie, Y., Erasmus, J., Cweya, A., Fry, S., Theunissen, M., Escosa García, L., Torrent, R., Torres Arauz, M., Guillén Martin, S., Boni, J., Mann, B., Saegesser, C., Ounchanum, P., Kaewmamueng, K., Srisuk, W., Kanjanavanit, S., Chutima, D., Chankun, T., Sudsaard, P., Kongsuk, K., Phunkhum, P., Kekitiinwa, A.R., Kirabira, A., Namuli, F., Kiyimba, L., Tikabibamu, J., Nabukeera Barung, N., Kityo, C.M., Kaudha, E., Ategeka, J., Mbabazi, R., Nabalamba, M., Nakalyango, A., Musiime, A., Mugarura, L., Katemba, C., Inyakuwal, C., Williams, E.D., Uyungrwoth, A., Raus, I., Mostovenko, O., Kenny, J., Ahmad, M., Nayagam, D., Ball, C., Hamlyn, E., Gilmour-White, S., Doshi, S., Fuller, E., Tupper, K., Irvine, E., Vaughn-Gordon, Y., Sibanda, N.

    Published in EClinicalMedicine (01-06-2023)
    “…Integrase inhibitor (INSTI) with boosted darunavir (DRV/r), a regimen with a high-resistance barrier, avoiding NRTI toxicities, might be a switching option in…”
    Get full text
    Journal Article
  13. 13

    Response to planned treatment interruptions in HIV infection varies across childhood by EUROPEAN, Paediatric

    Published in AIDS (London) (01-01-2010)
    “…To evaluate clinical, immunological and virological consequences of CD4-guided antiretroviral therapy (ART) planned treatment interruptions (PTIs) compared…”
    Get full text
    Journal Article
  14. 14

    Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trialResearch in context by Alexandra Compagnucci, Man K. Chan, Yacine Saïdi, Tim R. Cressey, Alasdair Bamford, Yoann Riault, Alexandra Coelho, Aoife Nolan, Suwalai Chalermpantmetagul, Gabija Morkunaite, Pauline Amuge, Victor Musiime, Avy Violari, Mark Cotton, Adeodata R. Kekitiinwa, Elizabeth Kaudha, Marisa Groenewald, Afaaf A. Liberty, Suparat Kanjanavanit, Alla Volokha, Rosa Bologna, Noris Pavia Ruz, Luis Prieto Tato, Paolo Paioni, Laura Marques, Véronique Reliquet, Tim Niehues, Steven B. Welch, Deborah Ford, Carlo Giaquinto, Diana M. Gibb, Abdel Babiker, Jose Tomas Ramos Amador, A. Compagnucci, Y. Saidi, Y. Riault, A. Coelho, C. Kouakam, L. Picault, M. Ndiaye, L. Meyer, C. Cagnot, S. Circosta, L. Léger, S. Simanic, A. Arulananthan, D.M. Gibb, A. Babiker, M. Chan, D. Ford, F. Hudson, L. Harper, A. Bamford, A. Nolan, K. Widuch, S. Townsend, N. Van-Looy, L. Gao, E. Little, A. Turkova, S. Fabiane, J. Calvert, J. Blackstone, K. Scott, J. Inshaw, A. Nunn, A. Nardone, D. Bilardi, T.R. Cressey, S. Chalermpantmetagul, W. Khamduang, G. Jourdain, N. Ngo Giang Huong, D. Chinwong, C. Saenjum, R. Peongjakta, P. Sukrakanchana, L. Laomanit, A. Kaewbundit, J. Khamkon, K. Than-in-at, C. Meeboon, W. Sripaoraya, N. Krueduangkam, N. Kruenual, W. Khamjakkaew, S. Klinprung, C. Giaquinto, G. Morkunaite, D. Hirt, L. Prieto Tato, T. Niehues, D. Plonné, C. Morén, T. Noguera, M.A. Muñoz Fernández, R. Bologna, S. Arazi, A.G. Fedullo, M. Taicz

    Published in EClinicalMedicine (01-06-2023)
    “…Background: Integrase inhibitor (INSTI) with boosted darunavir (DRV/r), a regimen with a high-resistance barrier, avoiding NRTI toxicities, might be a…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Risk Factors for In Utero or Intrapartum Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1 in Thailand by Jourdain, Gonzague, Mary, Jean-Yves, Le Coeur, Sophie, Ngo-Giang-Huong, Nicole, Yuthavisuthi, Praparb, Limtrakul, Aram, Traisathit, Patrinee, Mcintosh, Kenneth, Lallemant, Marc

    Published in The Journal of infectious diseases (01-12-2007)
    “…Background. The identification of risk factors for in utero and intrapartum transmission of human immunodeficiency virus type 1 (HIV-1) is crucial to the…”
    Get full text
    Journal Article
  19. 19
  20. 20